Taysha Gene Therapies Q3 2026 Net Loss Widens 20% to $39.1 Million
Taysha Gene Therapies Q3 2026 Net Loss Widens 20% to $39.1 Million Taysha Gene Therapies’ third
Related stories
S&P 500 and Nasdaq fall as Nvidia CEO exit rattles AI stocks
The Dow was up 0.07%, while the S&P 500 and Nasdaq fell.
M impact | EQUITY | Nov 12, 2026, 03:21 PM UTC
Nasdaq 100 Falls 1.4% as Nvidia Turmoil Rattles AI Trade
The Nasdaq 100 fell 1.4%, while Nvidia tumbled 13% after CEO Jensen Huang was ousted, according to the report.
M impact | EQUITY | Nov 12, 2026, 03:16 PM UTC
AAON Expands Credit Facility to Up to $1.2 Billion
AAON said it refinanced and expanded its credit facility to up to $1.2 billion.
M impact | EQUITY | Nov 12, 2026, 03:11 PM UTC
Hyperliquid Nvidia Perpetual Futures Reach Nearly $2 Billion in 24-Hour Volume
The Nvidia-linked contract ranked second on Hyperliquid, behind Bitcoin perpetual futures.
M impact | EQUITY | Nov 12, 2026, 03:10 PM UTC
Page Industries Shares Plunge 13% as Higher Raw-Material Costs Hit Q2 Profitability
Page Industries shares fell 13% to Rs. 31,850, their lowest level since April, as investors reacted to second-quarter profitability pressure from higher raw-material costs.
M impact | EQUITY | Nov 12, 2026, 03:09 PM UTC
Maersk Opens Montevideo Logistics Facility With Investment Above USD 20 Million
Maersk opened a logistics facility in Montevideo, investing more than USD 20 million.
M impact | EQUITY | Nov 12, 2026, 03:07 PM UTC